Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Revolution Medicines, Inc. Director's Dealing 2021

Apr 12, 2021

30695_dirs_2021-04-12_8e47c83f-2f12-4b0e-9df0-33757a07caf3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Revolution Medicines, Inc. (RVMD)
CIK: 0001628171
Period of Report: 2021-04-08

Reporting Person: Svennilson Peter (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-08 Common Stock S 21710 $44.8041 Disposed 1619448 Indirect
2021-04-08 Common Stock S 24518 $44.8041 Disposed 1828862 Indirect
2021-04-09 Common Stock S 11600 $43.8258 Disposed 1607848 Indirect
2021-04-09 Common Stock S 13101 $43.8258 Disposed 1815761 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 685011 Indirect
Common Stock 685011 Indirect
Common Stock 20302 Direct

Footnotes

F1: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by The Column Group III, LP ("TCG III LP").

F2: The securities are directly held by TCG III LP. The Column Group III GP, LP ("TCG III GP") is the general partner of TCG III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are David Goeddel, the Reporting Person, a member of the Issuer's board of directors, and Tim Kutzkey (collectively, the "Managing Partners"). The Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

F3: The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by The Column Group III-A, LP ("TCG III-A LP").

F4: The securities are directly held by TCG III-A LP. TCG III GP is the general partner of TCG III-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are the Managing Partners. The Managing Partners may be deemed to share voting and investment power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

F5: The securities are directly held by Ponoi Capital, LP ("Ponoi LP"). Ponoi Management, LLC ("Ponoi LLC") is the general partner of Ponoi LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of Ponoi II LLC are the Managing Partners. The Managing Partners may be deemed to share voting and investment power with respect to such shares. Ponoi LLC and the each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares

F6: The securities are directly held by Ponoi Capital II, LP ("Ponoi II LP"). Ponoi II Management, LLC ("Ponoi II LLC") is the general partner of Ponoi II LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of Ponoi II LLC are the Managing Partners. The Managing Partners may be deemed to share voting and investment power with respect to such shares. Ponoi II LLC and the each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.